Raw JSON Patch
[
{
"op": "replace",
"path": "/protocolSection/statusModule/statusVerifiedDate",
"value": "2022-04"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdateSubmitDate",
"value": "2022-04-05"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
"value": "2022-05-03"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdatePostDateStruct/type",
"value": "ACTUAL"
},
{
"op": "replace",
"path": "/protocolSection/sponsorCollaboratorsModule/collaborators/0/name",
"value": "Celgene"
},
{
"op": "replace",
"path": "/protocolSection/armsInterventionsModule/interventions/0/description",
"value": "<p>Phase I: dose-escalating portion with the starting dose of amrubicin at 90mg/m^2 IV q21 days.\nDose escalations are as follows:</p><p>DL2 - 100mg/m^2; DL3 - 110mg/m^2; and DL4 - 120mg/m^2.\nAll cycles are q21 days</p><p>Phase II: Amrubicin will be administered at the maximum tolerated dose established in Phase I by IV every 21 days</p>"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/primaryOutcomes/0/measure",
"value": "Progression-Free Survival (PFS) of MTD/Phase II Patients"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/primaryOutcomes/0/description",
"value": "Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on the study.\nProgression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, a measurable increase in a non-target lesion, or the appearance of new lesions.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/0/description",
"value": "Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs)."
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/0/timeFrame",
"value": "every 6 weeks until treatment discontinuation, up to 43 months"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/1/measure",
"value": "Overall Survival (OS) of MTD/Phase II Patients"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/1/description",
"value": "Measured from Day 1 of study drug administration to date of death due to any cause.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to this outcome measure."
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/1/timeFrame",
"value": "every 6 weeks until treatment discontinuation, up to 43 months"
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/2/description",
"value": "The number of patients with observed complete response [CR] or partial response [PR].\nPer Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), >=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
},
{
"op": "replace",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/2/timeFrame",
"value": "every 6 weeks until treatment discontinuation, up to 43 months"
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/groups/4",
"value": {
"id": "FG004",
"title": "Phase II",
"description": "Amrubicin - 110 mg/m^2 IV every 21 days"
}
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/periods/0/title",
"value": "Overall Study"
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/4",
"value": {
"groupId": "FG004",
"numSubjects": "63"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/1/achievements/4",
"value": {
"groupId": "FG004",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/4",
"value": {
"groupId": "FG004",
"numSubjects": "63"
}
},
{
"op": "remove",
"path": "/resultsSection/participantFlowModule/periods/1"
},
{
"op": "remove",
"path": "/resultsSection/baselineCharacteristicsModule/populationDescription"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/0/title",
"value": "Phase I - Dose Level 1"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/0/description",
"value": "Amrubicin -90 mg/m^2 by intravenous(IV) every 21days"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/1",
"value": {
"id": "BG001",
"title": "Phase I - Dose Level 2",
"description": "Amrubicin -100 mg/m^2 IV every 21days"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/2",
"value": {
"id": "BG002",
"title": "Phase I - Dose Level 3",
"description": "Amrubicin -110 mg/m^2 IV every 21days"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/3",
"value": {
"id": "BG003",
"title": "Phase I - Dose Level 4",
"description": "Amrubicin -120 mg/m^2 every 21 days"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/4",
"value": {
"id": "BG004",
"title": "Phase II - Dose Level 3",
"description": "Amrubicin -110 mg/m^2 IV every 21days"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/5",
"value": {
"id": "BG005",
"title": "Total",
"description": "Total of all reporting groups"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/0/value",
"value": "3"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/1",
"value": {
"value": "3",
"groupId": "BG001"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/2",
"value": {
"value": "3",
"groupId": "BG002"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/3",
"value": {
"value": "6",
"groupId": "BG003"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/4",
"value": {
"value": "63",
"groupId": "BG004"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/5",
"value": {
"value": "78",
"groupId": "BG005"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/title",
"value": "Age, Categorical"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/paramType",
"value": "COUNT_OF_PARTICIPANTS"
},
{
"op": "remove",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/dispersionType"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/unitOfMeasure",
"value": "Participants"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/value",
"value": "0"
},
{
"op": "remove",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/lowerLimit"
},
{
"op": "remove",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/upperLimit"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1",
"value": {
"value": "0",
"groupId": "BG001"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/2",
"value": {
"value": "0",
"groupId": "BG002"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/3",
"value": {
"value": "0",
"groupId": "BG003"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/4",
"value": {
"value": "0",
"groupId": "BG004"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/5",
"value": {
"value": "0",
"groupId": "BG005"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/title",
"value": "<=18 years"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/1",
"value": {
"title": "Between 18 and 65 years",
"measurements": [
{
"value": "3",
"groupId": "BG000"
},
{
"value": "2",
"groupId": "BG001"
},
{
"value": "3",
"groupId": "BG002"
},
{
"value": "6",
"groupId": "BG003"
},
{
"value": "44",
"groupId": "BG004"
},
{
"value": "58",
"groupId": "BG005"
}
]
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/2",
"value": {
"title": ">=65 years",
"measurements": [
{
"value": "0",
"groupId": "BG000"
},
{
"value": "1",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "19",
"groupId": "BG004"
},
{
"value": "20",
"groupId": "BG005"
}
]
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/0/value",
"value": "3"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/1",
"value": {
"value": "3",
"groupId": "BG001"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/2",
"value": {
"value": "3",
"groupId": "BG002"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/3",
"value": {
"value": "6",
"groupId": "BG003"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/4",
"value": {
"value": "63",
"groupId": "BG004"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/5",
"value": {
"value": "78",
"groupId": "BG005"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/1",
"value": {
"value": "0",
"groupId": "BG001"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/2",
"value": {
"value": "0",
"groupId": "BG002"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/3",
"value": {
"value": "0",
"groupId": "BG003"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/4",
"value": {
"value": "0",
"groupId": "BG004"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/5",
"value": {
"value": "0",
"groupId": "BG005"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/title",
"value": "Ethnicity (NIH/OMB)"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/paramType",
"value": "COUNT_OF_PARTICIPANTS"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/unitOfMeasure",
"value": "Participants"
},
{
"op": "remove",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/title"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/0/value",
"value": "0"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/1",
"value": {
"value": "0",
"groupId": "BG001"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/2",
"value": {
"value": "0",
"groupId": "BG002"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/3",
"value": {
"value": "1",
"groupId": "BG003"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/4",
"value": {
"value": "3",
"groupId": "BG004"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/5",
"value": {
"value": "4",
"groupId": "BG005"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/title",
"value": "Hispanic or Latino"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1",
"value": {
"title": "Not Hispanic or Latino",
"measurements": [
{
"value": "1",
"groupId": "BG000"
},
{
"value": "1",
"groupId": "BG001"
},
{
"value": "3",
"groupId": "BG002"
},
{
"value": "5",
"groupId": "BG003"
},
{
"value": "53",
"groupId": "BG004"
},
{
"value": "63",
"groupId": "BG005"
}
]
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/2",
"value": {
"title": "Unknown or Not Reported",
"measurements": [
{
"value": "2",
"groupId": "BG000"
},
{
"value": "2",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "7",
"groupId": "BG004"
},
{
"value": "11",
"groupId": "BG005"
}
]
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3",
"value": {
"title": "Race (NIH/OMB)",
"classes": [
{
"categories": [
{
"title": "American Indian or Alaska Native",
"measurements": [
{
"value": "0",
"groupId": "BG000"
},
{
"value": "0",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "0",
"groupId": "BG004"
},
{
"value": "0",
"groupId": "BG005"
}
]
},
{
"title": "Asian",
"measurements": [
{
"value": "0",
"groupId": "BG000"
},
{
"value": "0",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "0",
"groupId": "BG004"
},
{
"value": "0",
"groupId": "BG005"
}
]
},
{
"title": "Native Hawaiian or Other Pacific Islander",
"measurements": [
{
"value": "0",
"groupId": "BG000"
},
{
"value": "0",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "0",
"groupId": "BG004"
},
{
"value": "0",
"groupId": "BG005"
}
]
},
{
"title": "Black or African American",
"measurements": [
{
"value": "1",
"groupId": "BG000"
},
{
"value": "0",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "7",
"groupId": "BG004"
},
{
"value": "8",
"groupId": "BG005"
}
]
},
{
"title": "White",
"measurements": [
{
"value": "2",
"groupId": "BG000"
},
{
"value": "3",
"groupId": "BG001"
},
{
"value": "3",
"groupId": "BG002"
},
{
"value": "6",
"groupId": "BG003"
},
{
"value": "53",
"groupId": "BG004"
},
{
"value": "67",
"groupId": "BG005"
}
]
},
{
"title": "More than one race",
"measurements": [
{
"value": "0",
"groupId": "BG000"
},
{
"value": "0",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "0",
"groupId": "BG004"
},
{
"value": "0",
"groupId": "BG005"
}
]
},
{
"title": "Unknown or Not Reported",
"measurements": [
{
"value": "0",
"groupId": "BG000"
},
{
"value": "0",
"groupId": "BG001"
},
{
"value": "0",
"groupId": "BG002"
},
{
"value": "0",
"groupId": "BG003"
},
{
"value": "3",
"groupId": "BG004"
},
{
"value": "3",
"groupId": "BG005"
}
]
}
]
}
],
"paramType": "COUNT_OF_PARTICIPANTS",
"unitOfMeasure": "Participants"
}
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/title",
"value": "Progression-Free Survival (PFS) of MTD/Phase II Patients"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/description",
"value": "Progression-free survival is measured from Day 1 of study drug administration to disease progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1, or death on the study.\nProgression is defined in RECIST v1.1 as a 20% increase in the sum of the longest diameter of target lesions, a measurable increase in a non-target lesion, or the appearance of new lesions.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/populationDescription",
"value": "Patients who received the dose level 3 MTD dose/Phase II dose (Amrubicin -110 mg/m^2) are included in the analysis.\nThe 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD/phase II dose.\nThe phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.\nThe other 12 phase I pts who were not treated at the MTD are excluded."
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/description",
"value": "Assessments will be made through analysis of the reported incidence of treatment-emergent Serious Adverse Events (SAEs) and non-serious adverse events (AEs)."
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/populationDescription"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/paramType",
"value": "COUNT_OF_PARTICIPANTS"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/unitOfMeasure",
"value": "Participants"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/timeFrame",
"value": "every 6 weeks until treatment discontinuation, up to 43 months"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/0/title",
"value": "Dose Level 1"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/0/description",
"value": "Amrubicin -90 mg/m^2 by intravenous(IV) every 21days"
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/1",
"value": {
"id": "OG001",
"title": "Dose Level 2",
"description": "Amrubicin -100 mg/m^2 IV every 21days"
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/2",
"value": {
"id": "OG002",
"title": "Dose Level 3",
"description": "Amrubicin -110 mg/m^2 IV every 21days"
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/groups/3",
"value": {
"id": "OG003",
"title": "Dose Level 4",
"description": "Amrubicin -120 mg/m^2 IV every 21 days"
}
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/0/value",
"value": "3"
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/1",
"value": {
"value": "3",
"groupId": "OG001"
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/2",
"value": {
"value": "66",
"groupId": "OG002"
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/denoms/0/counts/3",
"value": {
"value": "6",
"groupId": "OG003"
}
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/title"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/0/value",
"value": "3"
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/1",
"value": {
"value": "3",
"groupId": "OG001"
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/2",
"value": {
"value": "65",
"groupId": "OG002"
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/0/categories/0/measurements/3",
"value": {
"value": "6",
"groupId": "OG003"
}
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/1/classes/1"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/title",
"value": "Overall Survival (OS) of MTD/Phase II Patients"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/description",
"value": "Measured from Day 1 of study drug administration to date of death due to any cause.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to this outcome measure."
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/populationDescription",
"value": "Patients who received the dose level 3 MTD dose/Phase II dose (Amrubicin -110 mg/m^2) are included in the analysis.\nThe 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD/phase II dose.\nThe phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.\nThe other 12 phase I pts who were not treated at the MTD are excluded."
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/2/timeFrame",
"value": "every 6 weeks until treatment discontinuation, up to 43 months"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/3/description",
"value": "The number of patients with observed complete response [CR] or partial response [PR].\nPer Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1) for target lesions and assessed by MRI: Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), >=30% decrease in the sum of the longest diameter of target lesions; Overall Response (OR) = CR + PR.\nThis outcome measure is reported for all patients treated at the same dose level and is not separated into Phase I and Phase II.\nThe phase I and phase II results are not separated as the timing of enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure."
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/3/populationDescription",
"value": "Patients who received the dose level 3 MTD dose/Phase II dose (Amrubicin -110 mg/m^2) are included in the analysis.\nThe 3, dose level 3 phase I pts and 63 phase II pts treated at this dose level are all combined to evaluate the efficacy of the MTD/phase II dose.\nThe phase I and phase II results are not separated out as the timing of their enrollment (early in phase 1 or later phase II) is not relevant to the outcome measure.\nThe other 12 phase I pts who were not treated at the MTD are excluded."
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/3/timeFrame",
"value": "every 6 weeks until treatment discontinuation, up to 43 months"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/description",
"value": "All patients who received at least one dose of protocol treatment were followed for safety.\nAdverse events and serious adverse events were collected from the day of the first dose to 30 days after the last dose of the study medication and graded according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/title",
"value": "Dose Level 1"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/description",
"value": "Amrubicin - 90 mg/m^2 by intravenous (IV) every 21 days"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAtRisk",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/otherNumAffected",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/otherNumAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/eventGroups/1",
"value": {
"id": "EG001",
"title": "Dose Level 2",
"description": "Amrubicin - 100 mg/m^2 by intravenous (IV) every 21 days",
"otherNumAtRisk": 3,
"otherNumAffected": 3,
"seriousNumAtRisk": 3,
"seriousNumAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/eventGroups/2",
"value": {
"id": "EG002",
"title": "Dose Level 3 (MTD)/Phase II",
"description": "Amrubicin - 110 mg/m^2 by intravenous (IV) every 21 days Includes patients treated at the MTD in Dose Level 3 phase 1 and in phase II",
"otherNumAtRisk": 66,
"otherNumAffected": 65,
"seriousNumAtRisk": 66,
"seriousNumAffected": 5
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/eventGroups/3",
"value": {
"id": "EG003",
"title": "Dose Level 4",
"description": "Amrubicin - 120 mg/m^2 by intravenous (IV) every 21 days",
"otherNumAtRisk": 6,
"otherNumAffected": 6,
"seriousNumAtRisk": 6,
"seriousNumAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/4/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/5/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/6/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/7",
"value": {
"term": "NEUTROPHIL COUNT DECREASED",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE v 4.0"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/8",
"value": {
"term": "THROMBOCYTOPENIA",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 2,
"numAffected": 1
},
{
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
],
"organSystem": "Blood and lymphatic system disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE v 4.0"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/9",
"value": {
"term": "PULMONARY INFILTERATES",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
],
"organSystem": "Respiratory, thoracic and mediastinal disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE v 4.0"
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 9,
"numAffected": 4
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 17,
"numAffected": 6
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 39,
"numAffected": 8
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numEvents",
"value": 6
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAffected",
"value": 2
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 126,
"numAffected": 32
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 6,
"numAffected": 3
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numEvents",
"value": 7
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 12,
"numAffected": 3
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 130,
"numAffected": 27
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 5,
"numAffected": 3
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 7,
"numAffected": 2
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 40,
"numAffected": 21
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 5,
"numAffected": 3
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 7,
"numAffected": 4
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 2,
"numAffected": 2
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 39,
"numAffected": 14
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 12,
"numAffected": 6
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 16,
"numAffected": 8
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 49,
"numAffected": 15
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 13,
"numAffected": 6
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 48,
"numAffected": 18
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 2,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 26,
"numAffected": 9
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 13,
"numAffected": 4
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 5,
"numAffected": 5
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 13,
"numAffected": 4
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/16/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 24,
"numAffected": 9
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/17/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 13,
"numAffected": 12
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/18/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 9,
"numAffected": 4
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/19/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 5,
"numAffected": 5
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/20/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/0/numEvents",
"value": 2
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/0/numAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 49,
"numAffected": 10
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/21/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 4,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 19,
"numAffected": 7
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/22/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/0/numEvents",
"value": 5
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/0/numAffected",
"value": 2
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 11,
"numAffected": 2
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 203,
"numAffected": 47
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/23/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 10,
"numAffected": 4
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 4,
"numAffected": 4
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/24/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 16,
"numAffected": 9
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/25/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/0/numEvents",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/0/numAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 15,
"numAffected": 8
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/26/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 7,
"numAffected": 4
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/27/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 9,
"numAffected": 5
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/28/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 9,
"numAffected": 3
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 83,
"numAffected": 34
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/29/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 7,
"numAffected": 3
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 1,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 11,
"numAffected": 9
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/30/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 3,
"numAffected": 2
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 41,
"numAffected": 8
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/31/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/0/numEvents",
"value": 6
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/0/numAffected",
"value": 2
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 9,
"numAffected": 2
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 82,
"numAffected": 25
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/32/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 5,
"numAffected": 4
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 58,
"numAffected": 11
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/33/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 8,
"numAffected": 3
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 87,
"numAffected": 36
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/34/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 8,
"numAffected": 5
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 17,
"numAffected": 7
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/35/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 4,
"numAffected": 2
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 49,
"numAffected": 19
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/36/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 9,
"numAffected": 5
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 5,
"numAffected": 5
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/37/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 2,
"numAffected": 1
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 26,
"numAffected": 15
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/38/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 2,
"numAffected": 2
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/0/numEvents",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/0/numAtRisk",
"value": 3
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/1",
"value": {
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 11,
"numAffected": 6
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/39/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 0,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/40",
"value": {
"term": "PAIN",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 3,
"numEvents": 3,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 3,
"numEvents": 14,
"numAffected": 2
},
{
"groupId": "EG002",
"numAtRisk": 66,
"numEvents": 0,
"numAffected": 0
},
{
"groupId": "EG003",
"numAtRisk": 6,
"numEvents": 15,
"numAffected": 4
}
],
"organSystem": "General disorders",
"assessmentType": "SYSTEMATIC_ASSESSMENT",
"sourceVocabulary": "CTCAE v 4.0"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/timeFrame",
"value": "every 3 weeks up to 43 months"
}
]